Rockefeller University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rockefeller University sits in the top decile of US sponsors by registered trial count (#222 of 15,742 sponsors by registered trial count).
Rockefeller University: 117 sponsored US clinical trials, 5 recruiting.
Rockefeller University sponsors 117 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 92 completed. 7 of these trials are in Phase 3-4 (later-stage) and 43 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 5 trials.
Top-decile sponsor footprint
Rockefeller University ranks in the top decile of sponsors by registered trial count (#222 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
92 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
117 total, page 3 of 3
Experiments to Test How and Why the Sense of Smell Differs Between People
NCT00220038
Phase I/II, Open-Label Trial of Three Monoclonal Antibodies
NCT00219986
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
NCT00115076
Effect of Folate on Colon and Blood Cells
NCT00220012
Study of the Immune Response to Hepatitis C Virus
NCT00237432
The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure
NCT00234130
Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.
NCT00289341
Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
NCT00219934
Hepatitis C Virus and the Humoral Immune System
NCT00219999
Effects of Leptin Treatment on Weight Loss
NCT00050791
Viral and Host Factors in the Transmission and Pathogenesis of HIV
NCT00219947
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
NCT00481637
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
NCT00050648
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris
NCT00050661
The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
NCT00327236
A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
NCT00002392
Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2
NCT00002017
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 6 |
| Phase 3 | 2 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the Rockefeller University pipeline
5 recruiting of 117 indexed (4% open); 92 completed (79%).
Phase mix: 7 late (III/IV) vs 43 early (I/II) (early-phase heavy).
Top condition: Obesity (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rockefeller University: open-pipeline peers nationwide
Peers matched on 117 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Rockefeller University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 117 trials (± recruiting share)
- San Diego State University · 118 trials · 27% recruiting
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Craig L Slingluff, Jr · 4% recruiting · 23 trials
- Esperion Therapeutics · 4% recruiting · 23 trials
- Tonix Pharmaceuticals · 4% recruiting · 23 trials
- National Institute on Drug Abuse (NIDA) · 4% recruiting · 335 trials
Related
What to do with this Rockefeller University page
117 registered trials is a research-attention snapshot, not an endorsement of Rockefeller University or any single study.
- 5 of Rockefeller University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Rockefeller University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rockefeller University pipeline card: 117 registered trials from official public datasets.Report a data error.